Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2/3 × Wilms Tumor × Decitabine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1 Myeloid 1 Genitourinary 1

Conditions

Leukemia, Myeloid, Acute 8 Myelodysplastic Syndromes 3 Wilms Tumor 1 TP53 1 Primary Malignant Neoplasm of Ovary 1 Older Patients 1 Hodgkin Disease 1 GATA2 Deficiency 1 Allogeneic Hematopoietic Stem Cell Transplantation 1

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01809392 2013-03-12

Decitabine Augments for Post Allogeneic Stem Cell Transplantation in Patients With Acute Myeloid Leukemia and Myelodysplastic Syndrome

The First Affiliated Hospital of Soochow University

Phase 2/3 Unknown

GenitourinaryMyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Wilms Tumor, Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon ⚡